HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Youle, R. J. Articles by Colombatti, M. Search for Related Content PubMed PubMed Citation Articles by Youle, R. J. Articles by Colombatti, M. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 262, Issue 10, 4676-4682, Apr, 1987

Hybridoma cells containing intracellular anti-ricin antibodies show ricin meets secretory antibody before entering the cytosol

RJ Youle and M Colombatti

Hybridoma cells which synthesize monoclonal antibodies (mAb) that block ricin toxicity were 50-300-fold resistant to ricin compared with other hybridomas. Two of the mAb blocked two isozymes of ricin, D and E, to different and opposite extents, and the hybridoma cell resistance to the two forms of ricin closely corresponded with the mAb reactivity. The hybridoma cell resistance to ricin was therefore due to the binding activity of the mAb produced by the cells. Neither rabbit polyclonal antibodies, which neutralized extracellular anti-ricin mAb, nor quantitative removal of hybridoma cell surface IgG with papain affected the cellular resistance to ricin. Therefore, neither extracellular or cell surface antibodies contributed to the resistance of the hybridoma cells. In contrast, inhibition of protein synthesis by cycloheximide or puromycin, which selectively decreased levels of intracellular secretory IgG, decreased the hybridoma cell resistance to ricin. We conclude that intracellular mAb, synthesized de novo for subsequent secretion, block ricin toxicity. Ricin therefore must meet intracellular secretory antibodies before reaching the cytosol. The monoclonal antibodies can also be used to study toxin function within intracellular compartments. An antibody specific for the galactose- binding site of ricin blocks ricin intracellularly, showing that the ricin galactose-binding activity is required in an intracellular compartment for transport of ricin A chain to the cytosol.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. J. Mantis, C. R. McGuinness, O. Sonuyi, G. Edwards, and S. A. Farrant Immunoglobulin A Antibodies against Ricin A and B Subunits Protect Epithelial Cells from Ricin Intoxication. Infect. Immun., June 1, 2006; 74(6): 3455 - 3462. [Abstract] [Full Text] [PDF]

				M. Maddaloni, C. Cooke, R. Wilkinson, A. V. Stout, L. Eng, and S. H. Pincus Immunological Characteristics Associated with the Protective Efficacy of Antibodies to Ricin J. Immunol., May 15, 2004; 172(10): 6221 - 6228. [Abstract] [Full Text] [PDF]

				S. Higuchi, T. Tamura, and T. Oda Cross-Talk between the Pathways Leading to the Induction of Apoptosis and the Secretion of Tumor Necrosis Factor-{alpha} in Ricin-Treated RAW 264.7 Cells J. Biochem., December 1, 2003; 134(6): 927 - 933. [Abstract] [Full Text] [PDF]

				L Greenfield, V. Johnson, and R. Youle Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity Science, October 23, 1987; 238(4826): 536 - 539. [Abstract] [PDF]